News
By working with Puerto Rican and Black people who sell drugs in Philadelphia to design and pilot a drug overdose and HIV prevention intervention, they aim to reverse the historical exclusion of people who sell drugs from public health research and harm reduction interventions.
The new model introduces a human-centered approach to integrating AI into complex, real-world settings.
The new initiative will advance research, education, and training at the intersection of AI and social impact by bringing together leading scholars across disciplines.
SIG Co-Director Victoria Frye and doctoral student Madison Xiaoyao Bogard presented research from the ENVIO and NNHIV studies.
Drs. Charles Lea and Elwin Wu, and Zichen “Jackson” Zhao, led a symposium presenting research from the gAyI initiative focused on how AI technologies can be better leveraged to support LGBTQ+ mental health and wellbeing.
Over four weeks with follow-ups, people who used fentanyl test strips reported more frequent engagement in seven of eight surveyed risk reduction behaviors.
Breaking down the cost of the intervention across its multiple dimensions provides valuable information for other communities considering how to address the opioid epidemic.
Sharing findings from the E-WORTH study, Dr. Goddard-Eckrich emphasizes the importance of culturally tailored HIV interventions for Black women.
HIV stigma in Kazakhstan drives low testing uptake and HIV status awareness, and the JasSpark study provides insight into one method to lower that stigma.
40 overdose deaths were averted across the study's 67 participating communities, saving hundreds of thousands of dollars in healthcare spending.
In Undark Magazine, SIG Director and University Professor Nabila El-Bassel lays out how diverse local coalitions can reduce overdose deaths and build lasting systems to prevent opioid overdoses.
Social Intervention Group researchers will highlight their work with presentations and by leading sessions and symposiums.
A new paper from the HEALing Communities Study shows that opioid education and naloxone distribution, one of the study's key arms, increased in the trial arm counties compared to those in the usual care arm of the study.
Dr. Engstrom, who received her MSW and PhD from Columbia, hopes to use this time to collaborate with SIG researchers and share her expertise about substance use and HIV in older women.
By tackling the complex topic of stigma and especially intersectional stigmas, Professor Davis hopes to gain insight into how to mitigate stigma and the negative effect it has on health outcomes.